Bristol-Myers Squibb Co.
€49.86
EUR
Last updated on --.
24h volume5.76M
24h highest51.4833 EUR
24h lowest49.8645 EUR
24h Price movement-2.39%
BMY recent prices
24 Hours
-2.39%-€1.221
30 days
+0.45%+€0.22339
60 days
+1.61%+€0.80765
90 days
-5.01%-€2.630
Key data
Previous close51.0880 EUR
Market cap102.71B EUR
Volume5.76M
P/E ratio16.430000
Dividend yield (TTM)0.04%
Dividend amount0.54130 EUR
Next ex-dividend dateApr 2, 2026
Next payment dateMay 1, 2026
EPS diluted (TTM)3.0588 EUR
Net income (FY)6.25B EUR
Revenue (FY)41.66B EUR
Last report dateApr 30, 2026
About Bristol-Myers Squibb Co.
HeadquartersPRINCETON
Employees (FY)32.50K
Revenue per employee (FY)1.28M EUR
Net income per employee (FY)192.28K EUR
Listed onNew York Stock Exchange
BMY conversion tables
 |  |
|---|---|
| 0.5 BMY | 24.93 EUR |
| 1 BMY | 49.86 EUR |
| 5 BMY | 249.33 EUR |
| 10 BMY | 498.67 EUR |
| |
|---|---|
| 0.5 EUR | 0.010026 BMY |
| 1 EUR | 0.020053 BMY |
| 5 EUR | 0.10026 BMY |
| 10 EUR | 0.20053 BMY |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BMY is trading at €49.86, -2.39% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BMY stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BMY is currently trading at €49.86, -2.39% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BMY price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BMY's P/E ratio is currently 16.430000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BMY; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BMY's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Bristol-Myers Squibb Co.'s market cap is currently 102.71B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume5.76M
24h highest51.4833 EUR
24h lowest49.8645 EUR
24h Price movement-2.39%
Start trade with BMY Perpetual
Sign up to trade